Arkolith/Insider Trading/AEON/Form 4/A

Daewoong Co., Ltd

10% OwnerAEON Biopharma, Inc. (AEON) · full profile →Form 4/A · filed Apr 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 12, 2024Other(J)0———

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-24-033564) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML